[144] GENPACT LIMITED SEC Filing
Genpact Limited (G) filing a Form 144 notifies the proposed sale of 18,218 common shares through Morgan Stanley Smith Barney LLC on the NYSE with an aggregate market value of $810,701.00. The shares were granted as performance shares and were acquired in two tranches: 11,351 on 01/10/2022 and 6,867 on 01/10/2023. The filing lists 174,270,076 shares outstanding for the class and indicates no reported sales by the seller in the past three months. The notice includes the seller鈥檚 representation that they are not aware of undisclosed material adverse information.
Genpact Limited (G) ha presentato un Form 144 per notificare la proposta vendita di 18.218 azioni ordinarie tramite Morgan Stanley Smith Barney LLC alla NYSE, per un valore complessivo di $810.701,00. Le azioni erano state attribuite come performance shares e sono state acquisite in due tranche: 11.351 il 01/10/2022 e 6.867 il 01/10/2023. Il documento indica 174.270.076 azioni in circolazione per la classe e segnala che il venditore non ha effettuato vendite nei tre mesi precedenti. La comunicazione riporta inoltre la dichiarazione del venditore di non essere a conoscenza di informazioni materiali avverse non divulgate.
Genpact Limited (G) present贸 un Form 144 para notificar la venta propuesta de 18.218 acciones ordinarias a trav茅s de Morgan Stanley Smith Barney LLC en la NYSE, con un valor agregado de $810.701,00. Las acciones fueron otorgadas como performance shares y se adquirieron en dos tramos: 11.351 el 01/10/2022 y 6.867 el 01/10/2023. El formulario indica 174.270.076 acciones en circulaci贸n para esa clase y se帽ala que el vendedor no report贸 ventas en los 煤ltimos tres meses. La notificaci贸n incluye la declaraci贸n del vendedor de no tener conocimiento de informaci贸n material adversa no divulgada.
Genpact Limited (G)電� Form 144毳� 鞝滌稖頃橃棳 NYSE鞐愳劀 Morgan Stanley Smith Barney LLC毳� 韱淀暣 18,218 氤错喌欤茧ゼ 毵る弰頃� 鞓堨爼鞛勳潉 韱奠頄堨溂氅�, 齑� 鞁滉皜鞎§潃 $810,701.00鞛呺媹雼�. 頃措嫻 欤检嫕鞚� performance shares搿� 攵�鞐悩鞐堦碃 11,351欤茧ゼ 2022/01/10鞐�, 6,867欤茧ゼ 2023/01/10鞐� 旆摑頃� 霊� 臧滌潣 韸鸽灉旃橂 甑劚霅橃柎 鞛堨姷雼堧嫟. 鞁犼碃靹滌棎電� 頃措嫻 韥措灅鞀れ潣 氚滍枆欤检嫕靾橁皜 174,270,076欤茧 旮办灛霅橃柎 鞛堨溂氅�, 韺愲Г鞛愲姅 歆�雮� 3臧滌洈臧� 毵る弰 雮挫棴鞚� 鞐嗢棃雼り碃 氇呾嫓霅橃柎 鞛堨姷雼堧嫟. 韱奠靹滌棎電� 瓿店皽霅橃 鞎婌潃 欷戨寑頃� 攵堧Μ頃� 鞝曤炒臧� 鞐嗢潓鞚� 韺愲Г鞛愱皜 歆勳垹頃� 雮挫毄霃� 韽暔霅橃柎 鞛堨姷雼堧嫟.
Genpact Limited (G) a d茅pos茅 un Form 144 pour notifier la vente projet茅e de 18 218 actions ordinaires via Morgan Stanley Smith Barney LLC 脿 la NYSE, pour une valeur totale de $810鈥�701,00. Les actions avaient 茅t茅 attribu茅es comme performance shares et ont 茅t茅 acquises en deux tranches : 11 351 le 01/10/2022 et 6 867 le 01/10/2023. Le dossier indique 174 270 076 actions en circulation pour cette cat茅gorie et pr茅cise que le vendeur n鈥檃 effectu茅 aucune vente au cours des trois derniers mois. L鈥檃vis inclut la d茅claration du vendeur selon laquelle il n鈥檃 pas connaissance d鈥檌nformations d茅favorables mat茅rielles non divulgu茅es.
Genpact Limited (G) hat ein Form 144 eingereicht, um den geplanten Verkauf von 18.218 Stammaktien 眉ber Morgan Stanley Smith Barney LLC an der NYSE mit einem Gesamtmarktwert von $810.701,00 zu melden. Die Aktien wurden als performance shares gew盲hrt und in zwei Tranchen erworben: 11.351 am 01.10.2022 und 6.867 am 01.10.2023. Die Einreichung nennt 174.270.076 ausstehende Aktien dieser Klasse und weist darauf hin, dass der Ver盲u脽erer in den letzten drei Monaten keine Verk盲ufe gemeldet hat. Die Mitteilung enth盲lt au脽erdem die Erkl盲rung des Verk盲ufers, dass ihm keine nicht offengelegten wesentlichen nachteiligen Informationen bekannt sind.
- Regulatory compliance: The filer provided required Rule 144 disclosure including broker, share count, and acquisition details
- Transparency: The filing states the seller has no undisclosed material adverse information and reports no sales in the past three months
- Insider sale: A proposed disposition of 18,218 common shares valued at $810,701 is reported
Insights
TL;DR: A routine insider notice to sell a small block of performance shares, disclosed pursuant to Rule 144.
The Form 144 reports a proposed sale of 18,218 shares valued at $810,701 via Morgan Stanley Smith Barney on the NYSE. The shares originated from performance awards granted in 2022 and 2023. Given the reported class outstanding of 174,270,076 shares, the proposed sale represents a de minimis fraction of the outstanding common stock. The filing follows disclosure requirements and includes the standard representation about lack of undisclosed material adverse information.
TL;DR: Compliance-focused disclosure of planned insider sale; procedural, not materially transformative.
The document is a procedural Rule 144 notice specifying the broker, number of shares, acquisition dates, and nature of acquisition (performance shares). It confirms no aggregated sales by the seller in the prior three months and includes the statutory signature attestations. There is no indication of any change in control, governance action, or material operational development disclosed here.
Genpact Limited (G) ha presentato un Form 144 per notificare la proposta vendita di 18.218 azioni ordinarie tramite Morgan Stanley Smith Barney LLC alla NYSE, per un valore complessivo di $810.701,00. Le azioni erano state attribuite come performance shares e sono state acquisite in due tranche: 11.351 il 01/10/2022 e 6.867 il 01/10/2023. Il documento indica 174.270.076 azioni in circolazione per la classe e segnala che il venditore non ha effettuato vendite nei tre mesi precedenti. La comunicazione riporta inoltre la dichiarazione del venditore di non essere a conoscenza di informazioni materiali avverse non divulgate.
Genpact Limited (G) present贸 un Form 144 para notificar la venta propuesta de 18.218 acciones ordinarias a trav茅s de Morgan Stanley Smith Barney LLC en la NYSE, con un valor agregado de $810.701,00. Las acciones fueron otorgadas como performance shares y se adquirieron en dos tramos: 11.351 el 01/10/2022 y 6.867 el 01/10/2023. El formulario indica 174.270.076 acciones en circulaci贸n para esa clase y se帽ala que el vendedor no report贸 ventas en los 煤ltimos tres meses. La notificaci贸n incluye la declaraci贸n del vendedor de no tener conocimiento de informaci贸n material adversa no divulgada.
Genpact Limited (G)電� Form 144毳� 鞝滌稖頃橃棳 NYSE鞐愳劀 Morgan Stanley Smith Barney LLC毳� 韱淀暣 18,218 氤错喌欤茧ゼ 毵る弰頃� 鞓堨爼鞛勳潉 韱奠頄堨溂氅�, 齑� 鞁滉皜鞎§潃 $810,701.00鞛呺媹雼�. 頃措嫻 欤检嫕鞚� performance shares搿� 攵�鞐悩鞐堦碃 11,351欤茧ゼ 2022/01/10鞐�, 6,867欤茧ゼ 2023/01/10鞐� 旆摑頃� 霊� 臧滌潣 韸鸽灉旃橂 甑劚霅橃柎 鞛堨姷雼堧嫟. 鞁犼碃靹滌棎電� 頃措嫻 韥措灅鞀れ潣 氚滍枆欤检嫕靾橁皜 174,270,076欤茧 旮办灛霅橃柎 鞛堨溂氅�, 韺愲Г鞛愲姅 歆�雮� 3臧滌洈臧� 毵る弰 雮挫棴鞚� 鞐嗢棃雼り碃 氇呾嫓霅橃柎 鞛堨姷雼堧嫟. 韱奠靹滌棎電� 瓿店皽霅橃 鞎婌潃 欷戨寑頃� 攵堧Μ頃� 鞝曤炒臧� 鞐嗢潓鞚� 韺愲Г鞛愱皜 歆勳垹頃� 雮挫毄霃� 韽暔霅橃柎 鞛堨姷雼堧嫟.
Genpact Limited (G) a d茅pos茅 un Form 144 pour notifier la vente projet茅e de 18 218 actions ordinaires via Morgan Stanley Smith Barney LLC 脿 la NYSE, pour une valeur totale de $810鈥�701,00. Les actions avaient 茅t茅 attribu茅es comme performance shares et ont 茅t茅 acquises en deux tranches : 11 351 le 01/10/2022 et 6 867 le 01/10/2023. Le dossier indique 174 270 076 actions en circulation pour cette cat茅gorie et pr茅cise que le vendeur n鈥檃 effectu茅 aucune vente au cours des trois derniers mois. L鈥檃vis inclut la d茅claration du vendeur selon laquelle il n鈥檃 pas connaissance d鈥檌nformations d茅favorables mat茅rielles non divulgu茅es.
Genpact Limited (G) hat ein Form 144 eingereicht, um den geplanten Verkauf von 18.218 Stammaktien 眉ber Morgan Stanley Smith Barney LLC an der NYSE mit einem Gesamtmarktwert von $810.701,00 zu melden. Die Aktien wurden als performance shares gew盲hrt und in zwei Tranchen erworben: 11.351 am 01.10.2022 und 6.867 am 01.10.2023. Die Einreichung nennt 174.270.076 ausstehende Aktien dieser Klasse und weist darauf hin, dass der Ver盲u脽erer in den letzten drei Monaten keine Verk盲ufe gemeldet hat. Die Mitteilung enth盲lt au脽erdem die Erkl盲rung des Verk盲ufers, dass ihm keine nicht offengelegten wesentlichen nachteiligen Informationen bekannt sind.
FAQ
What does Genpact's Form 144 filed under ticker G disclose?
When were the shares to be sold originally acquired?
How many Genpact shares are outstanding according to the filing?
Did the filer report any sales in the past three months?
Through which broker will the proposed sale occur?
